KLF4 and acute lymphoblastic leukemia: We further demonstrated that miR-2909 targeted the KLF4 3′UTR isolated from B-ALL patients, resulting in repression of KLF4 protein, but not that isolated from T-ALL patients with the mutated miR-2909 binding site, leading to increased levels of KLF4 protein.